Redeye updates its view on Verve Group following its Q2 2024 report, which was in line with the strong preliminary figures. The company continues to gain market share, and we are confident it will further improve its market position after attending the CMD, where several interesting insights were shared regarding product investments and ongoing market trends.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/